<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04865809</url>
  </required_header>
  <id_info>
    <org_study_id>2021-DIAB1</org_study_id>
    <nct_id>NCT04865809</nct_id>
  </id_info>
  <brief_title>Use of Ozonized Water With Toothpaste and Mousse in Non Surgical Periodontal Therapy for Patients With Diabetes Mellitus Type 1: a Randomized Clinical Trial.</brief_title>
  <official_title>Professional and Home Oral Care With Non Surgical Periodontal Therapy for the Evaluation of Glycosylated Hemoglobin (HbA1c) in Patients Suffering From Diabetes Mellitus Type 1: a Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the efficacy of Peribioma Toothpaste and Mousse for home&#xD;
      oral care in patients with Diabetes Mellitus Type 1.&#xD;
&#xD;
      Patients will undergo a professional oral hygiene procedure, followed by irrigation with&#xD;
      ozonized water.&#xD;
&#xD;
      Patients will be randomly divided into two groups:&#xD;
&#xD;
        -  Trial Group: patients will use Peribioma Toothpaste and Mousse for home oral care&#xD;
&#xD;
        -  Control Group: patients will use standard toothpastes for home oral care.&#xD;
&#xD;
      The variations of the following indices will be evaluated at the baseline, after 3 and 6&#xD;
      months: glycosylated hemoglobin (HbA1c) , Clinical Attachment Level (CAL), Probing Pocket&#xD;
      Depth (PPD) and Bleeding on Probing (BoP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the efficacy of Peribioma Toothpaste and Mousse for home&#xD;
      oral care in patients with Diabetes Mellitus Type 1.&#xD;
&#xD;
      Patients who respond to eligibility criteria and that will sign the informed consent will&#xD;
      undergo a professional oral hygiene procedure; then, ozonized water (aquolab) will be used to&#xD;
      irrigate periodontal pockets for 1 minute.&#xD;
&#xD;
      Then, patients will be randomly divided into two groups:&#xD;
&#xD;
        -  Trial Group: patients will use Peribioma Toothpaste and Mousse for home oral care until&#xD;
           the end of the study;&#xD;
&#xD;
        -  Control Group: patients will use standard toothpastes for home oral care until the end&#xD;
           of the study.&#xD;
&#xD;
      Changes in the following indices will be evaluated at the baseline, after 3 and 6 months:&#xD;
      glycosylated hemoglobin (HbA1c) , Clinical Attachment Level (CAL), Probing Pocket Depth (PPD)&#xD;
      and Bleeding on Probing (BoP).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 12, 2021</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Glycosylated Hemoglobin (HbA1c)</measure>
    <time_frame>Baseline, 3 and 6 months.</time_frame>
    <description>Serum levels of glycosylated hemoglobin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in CAL - Clinical Attachment Loss</measure>
    <time_frame>Baseline, 3 and 6 months.</time_frame>
    <description>Measurement (in mm) of the position of the gingival margin in relation to the cemento-enamel junction (CEJ).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in PI - Plaque Index (Silness and LÃ¶e, 1964)</measure>
    <time_frame>Baseline, 3 and 6 months.</time_frame>
    <description>Scoring criteria:&#xD;
0 = no plaque;&#xD;
= thin plaque layer at the gingival margin, only detectable by scraping with a probe;&#xD;
= moderate layer of plaque along the gingival margin; interdental spaces free, but plaque is visible to the naked eye;&#xD;
= abundant plaque along the gingival margin; interdental spaces filled with plaque.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in PPD - Probing Pocket Depth</measure>
    <time_frame>Baseline, 3 and 6 months.</time_frame>
    <description>Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in BOP - Bleeding on Probing (percentage)</measure>
    <time_frame>Baseline, 3 and 6 months.</time_frame>
    <description>Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 6 sites.&#xD;
Percentage of sites with bleeding on probing determines the BOP%.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Diabetes Mellitus With Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>Trial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients from this group will use Peribioma Toothpaste and Mousse for home oral care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients from this group will use standard toothpastes for home oral care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Peribioma Toothpaste and Mousse</intervention_name>
    <description>Use of Peribioma Toothpaste and Mousse for home oral care.</description>
    <arm_group_label>Trial Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard toothpaste</intervention_name>
    <description>Use of standard toothpastes for home oral care</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients suffering from Diabetes Mellitus Type 1&#xD;
&#xD;
          -  adult patients&#xD;
&#xD;
          -  patients who agreed to participate to the study and that signed the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients taking intravenous or oral Bisphosphonates at the study begin or in the&#xD;
             previous 12 months&#xD;
&#xD;
          -  patients with low compliance and motivation to participate&#xD;
&#xD;
          -  pazienti irradiati alla testa o collo negli ultimi 12 mesi&#xD;
&#xD;
          -  pregnant or breastfeeding women&#xD;
&#xD;
          -  alcohol and drug abuse&#xD;
&#xD;
          -  patients with psychiatric diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Scribante, DDS, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pavia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia</name>
      <address>
        <city>Pavia</city>
        <state>Lombardy</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Andrea Scribante</investigator_full_name>
    <investigator_title>Research Resident, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>ozonized water</keyword>
  <keyword>glycosylated hemoglobin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be available upon motivated request to Principal Investigator</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

